Deferred Tax Assets, Gross in USD of IMPACT BIOMEDICAL INC. from Q4 2022 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary
IMPACT BIOMEDICAL INC. quarterly Deferred Tax Assets, Gross history and change rate from Q4 2022 to Q4 2024.
  • IMPACT BIOMEDICAL INC. Deferred Tax Assets, Gross for the quarter ending 31 Dec 2024 was $4,416,000, a 24% increase year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Gross, Quarterly (USD)
Deferred Tax Assets, Gross, YoY Quarterly Change (%)

IMPACT BIOMEDICAL INC. Quarterly Deferred Tax Assets, Gross (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $4,416,000 +$862,000 +24% 31 Dec 2024 10-K 28 Mar 2025 2024 FY
Q4 2023 $3,554,000 +$764,000 +27% 31 Dec 2023 10-K 28 Mar 2025 2024 FY
Q4 2022 $2,790,000 31 Dec 2022 10-K 20 Feb 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.